588 filings
Page 4 of 30
SC 13D
ta18rupf0s65gbcf sq
30 Mar 17
Provectus Biopharmaceuticals, Inc.
12:00am
8-K
6chlk
23 Mar 17
Provectus Biopharmaceuticals Announces Terms
12:00am
SC 13D/A
nkfhud3wcyt0virwi0
21 Mar 17
Provectus Biopharmaceuticals, Inc.
12:00am
8-K
xdvawrip1m5nf04tqf
20 Mar 17
Regulation FD Disclosure
12:00am
NT 10-K
wah9vikwoz634z32e8yo
16 Mar 17
Notice of late annual filing
12:00am
8-K
w00f0
6 Mar 17
Provectus Biopharmaceuticals, Inc. Announces Extension of
12:00am
424B3
3wz306gt76eokq
6 Mar 17
Prospectus supplement
12:00am
8-K
2q0dsuchdweu1xzuf
24 Feb 17
Regulation FD Disclosure
12:00am
8-K
hyp2fkkpyfqjzt 7xwb
23 Feb 17
Provectus Biopharmaceuticals Appoints Bruce Horowitz and Dominic Rodrigues As Special Advisers to the Board of Directors
12:00am
424B3
pj7kjs6
21 Feb 17
Prospectus supplement
12:00am
8-K
qv1id khl5apfmkgxkx
21 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
gshwfbr gjc
14 Feb 17
Other Events
12:00am
8-K
0eni85 d6t
13 Feb 17
Provectus Biopharmaceuticals, Inc. Announces Extension of
12:00am
8-K
f0u8va xqv2
9 Feb 17
Regulation FD Disclosure
12:00am
424B3
dkxpox277edspukri lp
9 Feb 17
Prospectus supplement
12:00am
8-K
ezv35g9a 4mcf5
3 Feb 17
Entry into a Material Definitive Agreement
12:00am
424B4
nxmlnaw4f75polo5i
31 Jan 17
Prospectus supplement with pricing info
12:00am
8-K
e9tgfp92fx20382gqc
31 Jan 17
Provectus Biopharmaceuticals, Inc. Announces Commencement of
12:00am
SC 13D/A
9kriw 4fqxvn5ca4q3i
27 Jan 17
Provectus Biopharmaceuticals, Inc.
12:00am
EFFECT
ic69t814q
27 Jan 17
Notice of effectiveness
12:00am